Related Experiment Video
Updated: Jan 21, 2026
07:38
Author Spotlight: Modular Neuronal Networks for Analyzing Brain Functions
Published on: June 7, 2024
2.3K
Application of Micro-Scale 3D Printing in Pharmaceutics
1Department of Biological Engineering, Utah State University, Logan, UT 84322, USA.
Pharmaceutics
|August 7, 2019
Summary
Micro 3D printing offers innovative pharmaceutical solutions for controlled release and personalized medicine. This review explores recent advances, applications, and challenges in this rapidly evolving field.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Materials Science
Background:
- 3D printing technology has rapidly evolved over the past two decades.
- Its integration into the pharmaceutical field offers unique advantages, particularly at the micro-scale.
- Micro-scale 3D printing enables advanced solutions for drug delivery and development.
Purpose of the Study:
- To review recent advances in micro-scale 3D printing for pharmaceutical applications.
- To introduce 3D printing techniques relevant to pharmaceutical development stages.
- To summarize and group micro-sized pharmaceutical applications by their benefits.
Main Methods:
- Review of recent literature on micro-scale 3D printing in pharmaceuticals.
- Categorization of applications based on benefits such as controlled release, targeted delivery, and personalized medicine.
- Discussion of technical parameters and features of 3D printing techniques relevant to pharmaceutical development.
Main Results:
- Micro-scale 3D printing provides nuanced solutions for controlled release, minimally invasive delivery, and high-precision targeting.
- Applications include biomimetic models for drug discovery and development.
- Future opportunities for personalized medicine are significant.
Conclusions:
- Micro-scale 3D printing presents compelling future solutions for modern medicine.
- Challenges related to scale-up and regulatory approval need to be addressed.
- Continued innovation in 3D printing holds promise for advancing pharmaceutical development.
Related Concept Videos
01:26Pharmaceutical Equivalents
186
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
186
02:41pH Scale
79.0K
Hydronium and hydroxide ions are present both in pure water and in all aqueous solutions, and their concentrations are inversely proportional as determined by the ion product of water (Kw). The concentrations of these ions in a solution are often critical determinants of the solution’s properties and the chemical behaviors of its other solutes. Two different solutions can differ in their hydronium or hydroxide ion concentrations by a million, billion, or even trillion times. A common means of...
79.0K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
408
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
408
01:26Scaling
566
In designing and analyzing filters, resonant circuits, or circuit analysis at large, working with standard element values like 1 ohm, 1 henry, or 1 farad can be convenient before scaling these values to more realistic figures. This approach is widely utilized by not employing realistic element values in numerous examples and problems; it simplifies mastering circuit analysis through convenient component values. The complexity of calculations is thereby reduced, with the understanding that...
566
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
176
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
176